| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-08 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-08 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |